Latest irritable bowel syndrome Stories

2015-06-02 08:32:13

-- GI Clinician and Scientist Most Recently Served in Leadership Positions at Quintiles and the U.S.

2015-06-01 08:31:54

-- Leading Clinicians to Discuss Novel Approaches to Treating IBS-C and Preventing C.

2015-05-27 20:22:56

Xifaxan® 550 mg is the first-and-only nonsystemic antibiotic approved for the treatment of IBS-D in adults LAVAL, Quebec, May 27, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International,

2015-05-27 20:22:53

-First in class treatment for IBS-D treats hallmark symptoms of IBS-D; abdominal pain and diarrhea DUBLIN, May 27, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) announced today that

2015-05-18 12:28:21

-- Company's Irritable Bowel Syndrome with Constipation (IBS-C) Program to Reduce the Impact of Methane Gas in the Gut on Target to Initiate Phase 2 Clinical Trial in 2Q 2015 -- ROCKVILLE,

2015-05-18 12:28:18

Company will focus on probiotics and management of gastroenterological conditions GAITHERSBURG, Md., May 18, 2015 /PRNewswire-USNewswire/ -- ExeGi Pharma, a company focused on developing

2015-05-18 12:28:07

- In a group of IBS-M and IBS-D patients, IBgard® reduced eight hallmark symptoms of IBS in as early as 24 hours and further reduced these symptoms at 4 weeks WASHINGTON, May 18, 2015 /PRNewswire/

2015-05-08 16:25:28

Survey aims to shed light on irritable bowel syndrome and drive better communication between doctors and their patients BETHESDA, Md., May 8, 2015 /PRNewswire/ -- Today, the American

2015-05-05 16:31:54

-- Conference Call and Webcast Today at 5:00 p.m. ET -- FREMONT, Calif., May 5, 2015 /PRNewswire/ -- Ardelyx, Inc.

Word of the Day
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'